Expression and prognostic significance of Oct4 and Nanog in neuroblastoma

Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines

(2014) Thomas C. Newton et al.   Translational Oncology

Characteristics of glioma stem cells

(2013) Oltea Sampetrean et al.   Brain Tumor Pathology

Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model

(2013) Qiqi Zhu et al.   Cancer Cell International

PI3King on MYCN to Improve Neuroblastoma Therapeutics

(2012) Michael D. Hogarty et al.   CANCER CELL

Transcriptional Amplification in Tumor Cells with Elevated c-Myc

(2012) Charles Y. Lin et al.   CELL

Expression of Stem Cell Markers, CD133 and CD44, in Pediatric Solid Tumors: A Study Using Tissue Microarray

(2012) Mitra Mehrazma et al.   Fetal and Pediatric Pathology

Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer

(2012) Yang Jiang et al.   Gastric Cancer

NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth

(2012) Cristina Tringali et al.   INTERNATIONAL JOURNAL OF CANCER

CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer

(2012) Han Hong Lee et al.   JOURNAL OF SURGICAL ONCOLOGY

Medulloblastoma stem cells: where development and cancer cross pathways

(2012) Branavan Manoranjan et al.   PEDIATRIC RESEARCH

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification

(2012) L. J. Valentijn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence

(2011) Peng Huang et al.   MEDICAL ONCOLOGY

Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients

(2010) Mariarosa A.B. Melone et al.   CANCER BIOLOGY & THERAPY

Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens

(2010) Kristen M. Smith et al.   EMBO Molecular Medicine

Sall1 Regulates Embryonic Stem Cell Differentiation in Association with Nanog

(2010) Efthimia Karantzali et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of neuroblastoma stem cells by characterization of side population cells in the human neuroblastoma SK-N-SH cell line

(2010) Shiqin Qi et al.   JOURNAL OF PEDIATRIC SURGERY

Antitumor Immunity and Cancer Stem Cells

(2009) Tobias Schatton et al.   Annals of the New York Academy of Sciences

The transcriptional foundation of pluripotency

(2009) I. Chambers et al.   DEVELOPMENT

N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma

(2009) J. D. Kessler et al.   GENES & DEVELOPMENT

Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus

(2009) Yonatan Y. Mahller et al.   PLoS One

N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b

(2009) Rebecca Cotterman et al.   PLoS One

Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells

(2008) Feng Ye et al.   BMC CANCER

Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells

(2008) T. Mueller et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma

(2008) S.-H. Chiou et al.   CLINICAL CANCER RESEARCH

Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy

(2008) Madhuri Kakarala et al.   JOURNAL OF CLINICAL ONCOLOGY

Oct4/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells

(2008) D. A. Greer Card et al.   MOLECULAR AND CELLULAR BIOLOGY